We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+0.14%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$150M
AUM Growth
+$20.3M
(+16%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
10.5%
Top 10 Holdings %
Top 10 Hldgs %
9.04%
Holding
664
New
292
Increased
44
Reduced
53
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$1.11M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.11M |
| 3 |
Nike
NKE
|
+$1.03M |
| 4 |
PAY
Verifone Systems Inc
PAY
|
+$959K |
| 5 |
MON
Monsanto Co
MON
|
+$894K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.43M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.19M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.41M |
| 4 |
Enterprise Products Partners
EPD
|
+$1.02M |
| 5 |
Magna International
MGA
|
+$933K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.63% |
| 2 | Healthcare | 14.32% |
| 3 | Technology | 11.92% |
| 4 | Industrials | 11.68% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Allstate
ALL
$64.3B
| $424K | 0.28% |
6,300
-2,100
| -25% | -$132K |
|
127
Vulcan Materials
VMC
$37.4B
| $422K | 0.28% |
+4,000
| New | +$379K |
|
128
Voya Financial
VOYA
$9.04B
| $420K | 0.28% |
+14,100
| New | +$427K |
|
129
Arrow Electronics
ARW
$10.6B
| $419K | 0.28% |
+6,500
| New | +$361K |
|
130
AvalonBay Communities
AVB
$27.4B
| $418K | 0.28% |
+2,200
| New | +$388K |
|
131
Bath & Body Works
BBWI
$4.21B
| $413K | 0.28% |
+5,814
| New | +$417K |
|
|
ENDP
132
DELISTED
Endo International plc
ENDP
| $411K | 0.27% |
+14,600
| New | +$689K |
|
|
TLRD
133
DELISTED
Tailored Brands, Inc.
TLRD
| $406K | 0.27% |
+22,700
| New | +$350K |
|
|
AGR
134
DELISTED
Avangrid, Inc.
AGR
| $405K | 0.27% |
+10,100
| New | +$395K |
|
135
Western Alliance Bancorporation
WAL
$8.99B
| $404K | 0.27% |
12,100
+5,800
| +92% | +$181K |
|
|
CXO
136
DELISTED
CONCHO RESOURCES INC.
CXO
| $404K | 0.27% |
4,000
+900
| +29% | +$82.7K |
|
137
Electronic Arts
EA
$52.4B
| $403K | 0.27% |
6,100
+2,800
| +85% | +$179K |
|
|
OKS
138
DELISTED
Oneok Partners LP
OKS
| $402K | 0.27% |
+12,800
| New | +$361K |
|
139
Kohl's
KSS
$1.96B
| $401K | 0.27% |
+8,600
| New | +$404K |
|
140
RTX Corp
RTX
$261B
| $400K | 0.27% |
+6,356
| New | +$369K |
|
141
Tenet Healthcare
THC
$16.8B
| $399K | 0.27% |
+13,800
| New | +$359K |
|
142
Perrigo
PRGO
$1.48B
| $397K | 0.27% |
+3,100
| New | +$424K |
|
143
Brixmor Property Group
BRX
$9.99B
| $387K | 0.26% |
15,100
+5,800
| +62% | +$143K |
|
144
News Corp Class A
NWSA
$15.4B
| $387K | 0.26% |
+30,300
| New | +$359K |
|
145
G-III Apparel Group
GIII
$1.49B
| $386K | 0.26% |
+7,900
| New | +$382K |
|
146
Puma Biotechnology
PBYI
$434M
| $385K | 0.26% |
+13,100
| New | +$592K |
|
|
GWB
147
DELISTED
Great Western Bancorp, Inc.
GWB
| $385K | 0.26% |
+14,100
| New | +$361K |
|
148
Murphy USA
MUSA
$11.4B
| $381K | 0.25% |
6,200
-1,600
| -21% | -$98.5K |
|
149
Kirby Corp
KEX
$7.71B
| $380K | 0.25% |
6,300
-7,200
| -53% | -$393K |
|
|
BECN
150
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $377K | 0.25% |
+9,200
| New | +$350K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q1 2016 Portfolio in Review
As of Q1 2016, Fox Run Management held 664 positions worth $150M, up 16% from $129M the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Fox Run Management deployed $15.7M of net new capital in Q1 2016, opening 292 new positions and adding to 44 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.43M trimmed.
- Fox Run Management's largest Q1 2016 buy was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
- Fox Run Management added most to Hologic in Q1 2016, an estimated $823K increase.
- Fox Run Management's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.43M.
- Fox Run Management fully exited Enterprise Products Partners in Q1 2016, selling an estimated $1.02M.
- Fox Run Management's ten largest holdings make up 9% of its $150M portfolio in Q1 2016.
- Fox Run Management opened 292 new positions and closed 273 in Q1 2016.
- Fox Run Management's portfolio value rose 16% quarter-over-quarter to $150M.
Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.